World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
27708
World Ranking
19935
National Ranking
58

Overview

Alberto Gabizon is affiliated with Shaare Zedek Medical Center in Israel. Their research spans multiple disciplines including medicine, materials science, and engineering, with a particular focus on biomedical engineering and biomaterials. Their work intersects oncology, molecular biology, and surgery, reflecting a broad engagement with both fundamental and applied aspects of medical science.

The scientist has contributed extensively to topics such as nanoparticle-based drug delivery and nanoplatforms for cancer theranostics. Other research interests include RNA interference and gene delivery, cancer immunotherapy and biomarkers, cancer treatment and pharmacology, graphene and nanomaterials applications, alongside general cancer research and treatments.

Frequent coauthors in their publications include Hilary Shmeeda, Ninh M. La-Beck, Yasmine Amitay, Patricia Ohana, and Jalpa Patel, indicating collaborative work within a network of experts in related fields.

Alberto Gabizon has published numerous papers, with notable recent works including:

  • "Complement Activation: A Potential Threat on the Safety of Poly(ethylene glycol)-Coated Nanomedicines" (2020, ACS Nano)
  • "Translational considerations in nanomedicine: The oncology perspective" (2020, Advanced Drug Delivery Reviews)
  • "Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective" (2025, BMJ Oncology)
  • "Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions" (2024, ACS Nano)
  • "Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside" (2020, Advanced Drug Delivery Reviews)

The scientist's publications frequently appear in high-impact venues, including ACS Nano, Advanced Drug Delivery Reviews, Journal of Controlled Release, Pharmaceutics, and Cancer Immunology Research. This reflects the interdisciplinary nature and application breadth of their work.

Best Publications

  • Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

    Alberto Gabizon;Hilary Shmeeda;Yechezkel Barenholz

  • Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

    D Papahadjopoulos;T M Allen;A Gabizon;E Mayhew

  • Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.

    Alberto Gabizon;Raphael Catane;Beatrice Uziely;Bela Kaufman

  • Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

    Alberto Gabizon;Demetrios Papahadjopoulos

  • Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

    Uma Prabhakar;Hiroshi Maeda;Rakesh K. Jain;Eva M. Sevick-Muraca

  • Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

    D.D. Lasic;F.J. Martin;A. Gabizon;S.K. Huang

  • Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2

    T. Safra;F. Muggia;S. Jeffers;D. D. Tsao-Wei

  • Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.

    Alberto A. Gabizon

  • Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.

    Alberto Gabizon;Hilary Shmeeda;Hilary Shmeeda;Aviva T Horowitz;Aviva T Horowitz;Samuel Zalipsky;Samuel Zalipsky

  • Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes

    Alberto A. Gabizon

  • Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

    Beatrice Uziely;Susan Jeffers;Rut Isacson;Kimberlea Kutsch

  • Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

    Dorit Goren;Aviva T. Horowitz;Dina Tzemach;Mark Tarshish

  • Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.

    Janos Szebeni;Franco Muggia;Alberto Gabizon;Yechezkel Barenholz

  • Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma.

    Olga Lyass;Beatrice Uziely;Rami Ben-Yosef;Dinah Tzemach

  • Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.

    A Gabizon;A Dagan;D Goren;Y Barenholz

  • In Vivo Fate of Folate-Targeted Polyethylene-Glycol Liposomes in Tumor-Bearing Mice

    Alberto Gabizon;Aviva T. Horowitz;Dorit Goren;Dina Tzemach

  • Pros and Cons of the Liposome Platform in Cancer Drug Targeting

    Alberto A Gabizon;Hilary Shmeeda;Samuel Zalipsky

  • Pharmacokinetics and Tissue Distribution of Doxorubicin Encapsulated in Stable Liposomes With Long Circulation Times

    Alberto Gabizon;Renee Shiota;Demetrios Papahadjopoulos

  • Ultrasound triggered release of cisplatin from liposomes in murine tumors.

    Avi Schroeder;Reuma Honen;Keren Turjeman;Alberto Gabizon

  • Liposome circulation time and tumor targeting: implications for cancer chemotherapy

    Alberto A. Gabizon

Frequent Co-Authors

Yechezkel Barenholz
Yechezkel Barenholz Hebrew University of Jerusalem
John Maher
John Maher King's College London
Franco M. Muggia
Franco M. Muggia New York University
Demetrios Papahadjopoulos
Demetrios Papahadjopoulos University of California, San Francisco
Philip J. Blower
Philip J. Blower King's College London
Theresa M. Allen
Theresa M. Allen University of Alberta
Piotr Grodzinski
Piotr Grodzinski National Institutes of Health
Zvi Fuks
Zvi Fuks Memorial Sloan Kettering Cancer Center
Paolo Caliceti
Paolo Caliceti University of Padua
Janos Szebeni
Janos Szebeni Semmelweis University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a popular option, there are many related online degrees that can open doors to rewarding healthcare careers. For those interested in healthcare leadership and management, a health administration degree online provides essential skills in policy, finance, and operations.

If you're aiming for advanced roles, exploring the cheapest mha online programs can help you further specialize in healthcare administration while keeping costs affordable.

Expanding your clinical expertise? The best online bsn to dnp programs let registered nurses seamlessly earn a doctoral degree, preparing them for leadership, research, or academic roles.

Likewise, pharmacists can advance their education conveniently through online pharmd programs, gaining in-depth clinical and pharmaceutical knowledge.

These flexible online pathways offer accessible, affordable, and specialized career options for those drawn to the healthcare field, beyond the traditional route of earning a medical degree.

Best Scientists Citing Alberto Gabizon

Trending Scientists

Recently Published Articles